| |
| Physical Characters and Index |
Melting point: 157 - 158℃
Storage condition: Sealed in a dry environment at 2 - 8°C
Solubility: Soluble in DMSO (up to 30 mg/ml).
Form: Solid
Color: White |
| |
| Use and description |
| VGX-1027 is an orally active isoxazole compound that exhibits various immunomodulatory properties. VGX-1027 targets macrophages, reducing the production of the proinflammatory mediators TNF-α, IL-1β, IL-10. VGX-1027 has antidiabetogenic effects by limiting cytokine-mediated immunoinflammatory events |
|
